Seno Medical, a San Antonio, Texas firm, has won FDA approval to introduce its Imagio device that utilizes opto-acoustic imaging to help physicians identify whether breast lesions are benign or malignant. It is hoped that this non-invasive and radiation-free technology will help to reduce the number of biopsies that have to be performed.
(Read more...)